Literature DB >> 16828267

Preparing and evaluating delivery systems for proteins.

L Jorgensen1, E H Moeller, M van de Weert, H M Nielsen, S Frokjaer.   

Abstract

From a formulation perspective proteins are complex and therefore challenging molecules to develop drug delivery systems for. The success of a formulation depends on the ability of the protein to maintain the native structure and activity during preparation and delivery as well as during shipping and long-term storage of the formulation. Therefore, the development and evaluation of successful and promising drug delivery systems is essential. In the present review, some of the particulate drug delivery systems for parenteral delivery of protein are presented and discussed. The challenge for incorporation of protein in particulate delivery systems is exemplified by water-in-oil emulsions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16828267     DOI: 10.1016/j.ejps.2006.05.008

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

1.  Bovine β-lactoglobulin is dimeric under imitative physiological conditions: dissociation equilibrium and rate constants over the pH range of 2.5-7.5.

Authors:  Davide Mercadante; Laurence D Melton; Gillian E Norris; Trevor S Loo; Martin A K Williams; Renwick C J Dobson; Geoffrey B Jameson
Journal:  Biophys J       Date:  2012-07-17       Impact factor: 4.033

2.  Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release.

Authors:  Baeckkyoung Sung; Steven Shaffer; Michal Sittek; Talib Alboslemy; Chanjoong Kim; Min-Ho Kim
Journal:  J Vis Exp       Date:  2016-02-13       Impact factor: 1.355

3.  Promoting early neovascularization of SIS-repaired abdominal wall by controlled release of bioactive VEGF.

Authors:  Rui Tang; Xin Wang; Hanying Zhang; Xi Liang; Xueyi Feng; Xiaoqiang Zhu; Xinwu Lu; Fei Wu; Zhengni Liu
Journal:  RSC Adv       Date:  2018-01-25       Impact factor: 4.036

Review 4.  Polymer-based sustained-release dosage forms for protein drugs, challenges, and recent advances.

Authors:  Fei Wu; Tuo Jin
Journal:  AAPS PharmSciTech       Date:  2008-12-16       Impact factor: 3.246

5.  Design and evaluation of a novel nanoparticulate-based formulation encapsulating a HIP complex of lysozyme.

Authors:  Ripal Gaudana; Mitan Gokulgandhi; Varun Khurana; Deep Kwatra; Ashim K Mitra
Journal:  Pharm Dev Technol       Date:  2012-11-09       Impact factor: 3.133

6.  Development of dextran nanoparticles for stabilizing delicate proteins.

Authors:  Fei Wu; Zhihua Zhou; Jing Su; Liangming Wei; Weien Yuan; Tuo Jin
Journal:  Nanoscale Res Lett       Date:  2013-04-27       Impact factor: 4.703

7.  Encapsulation of Protein-Polysaccharide HIP Complex in Polymeric Nanoparticles.

Authors:  Ripal Gaudana; Varun Khurana; Ashwin Parenky; Ashim K Mitra
Journal:  J Drug Deliv       Date:  2011-04-27

8.  Identification and Assessment of Octreotide Acylation in Polyester Microspheres by LC-MS/MS.

Authors:  Mehrnoosh Shirangi; Wim E Hennink; Govert W Somsen; Cornelus F van Nostrum
Journal:  Pharm Res       Date:  2015-04-02       Impact factor: 4.200

9.  Novel preparation method for sustained-release PLGA microspheres using water-in-oil-in-hydrophilic-oil-in-water emulsion.

Authors:  Xiaoyun Hong; Liangming Wei; Liuqing Ma; Yinghui Chen; Zhenguo Liu; Weien Yuan
Journal:  Int J Nanomedicine       Date:  2013-07-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.